Example collocations logo

Firms in sentence

3712 examples of Firms in a sentence

With US military spending slowing and other export markets remaining tight, American defense firms are eager to expand sales to India, which is now the world’s largest arms importer.
The value of India’s arms contracts with US firms exceeds that of American military aid to any country except Israel.
It expands opportunities for more types of firms, individuals, and countries to participate in the global economy.
China, for example, has established its own digital industries, using policies such as Internet filtering, data localization (requiring Internet firms to store data on domestic servers), and forced technology transfer to drive digital development.
This has supported the emergence of major Chinese digital firms such as Tencent and Baidu, though it often has had adverse effects on freedom of expression and access to information.
Multinational digital firms, mostly based in the US, have pushed for globally harmonized rules that would provide predictability and limit the space for national governments to intervene in digital flows.
TTIP negotiations proved more challenging, with some European states, particularly France and Germany, opposing the rules out of fear that they would enable US firms to dominate the European digital economy.
One major reason for this is that current global rules have enabled a few large firms to capture an ever-larger share of the value-added from trade.
Specifically, the proliferation of global value chains has enabled powerful multinational firms to control the design, production, and distribution of traded goods and services, even as various segments are outsourced to smaller firms far from final markets.
These firms often benefit from intellectual-property monopolies, reinforced by free-trade agreements designed to strengthen corporate power.
The forthcoming Trade and Development Report 2018 by the United Nations Conference on Trade and Development (UNCTAD) captures how top firms have steadily increased their share of total exports, and now dominate global trade.
And, because Turkish banks and firms have borrowed heavily in foreign currency, the lira’s freefall threatens to bring much of the private sector down with it.
For its part, the AFM will calculate its benchmark separately for the eight major pharmaceutical companies that currently appear to be working on replacement drugs, generic producers, and firms focused solely on research and development.
The fact that only eight “Big Pharma” firms are even attempting to develop new antibiotics and vaccines is a cause for serious concern.
One of the more radical ideas we discussed during the Review concerned financial “pull” incentives to reward firms that successfully develop new drugs.
We determined that an effective market-entry reward could be funded by small levies on the sales of the other top-50 pharmaceutical firms that are not carrying their weight.
Of the eight Big Pharma firms that are included, the British company GlaxoSmithKline currently scores the highest.
Frankly, we would not classify all eight firms as being truly committed to the cause, but at least with the benchmark, they can now see clearly how they can improve.
Moreover, one hopes the benchmark will prod into action all of the firms that have not even bothered to join the fight against AMR.
And yet more than 70 of those firms do not appear on the AMF’s new index.
The benchmark’s third category concerns biotech firms, which conduct research into drugs that can combat the “priority pathogens” identified by the WHO.
The agenda includes an expansion of the tax base to reduce dependency on oil, an initiative to increase competition in media and telecommunications, and a constitutional change that will permit the state-owned oil company Pemex to enter into joint ventures with foreign firms.
Industries and firms, like people, have their own life cycles, and the pace of change in high-tech industries is unprecedented.
Since then firms like Microsoft and Intel exploited software and hardware revolutions that IBM and others had missed, and left IBM in the dust.
Still, European governments typically complain about the lack of fiscal resources to support R&D (a far fetched argument given the miniscule share of research spending in the oversized European budgets) and, whenever the European Commission allows them, they subsidize innovative firms, or those that they think are more likely to invest in R&D.
Subsidies will not produce efficient high-tech firms.
Rather than supporting R&D with large defense budgets, they prefer to do it directly, subsidizing French high-tech firms.
But many European countries still refuse to accept that some of their high-tech firms might not make it: better, they think, to keep them alive with generous subsidies, and in the meantime avoid the consolidation of EU defense budgets.
And yet for decades we thought that the people who were managing those firms were much smarter than we were.
That loophole allowed his former friends and colleagues on Wall Street to pay themselves billion-dollar bonuses while keeping those firms afloat with taxpayers’ money.
BackNext